Healthy Extracts Inc. (HYEX)
OTCMKTS · Delayed Price · Currency is USD
2.600
+0.350 (15.56%)
At close: Jun 1, 2026
Healthy Extracts Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5.19 | 4.51 | 3.11 | 2.49 | 2.25 | 1.68 | |
Revenue Growth (YoY) | 54.70% | 44.93% | 25.24% | 10.41% | 34.29% | 31.34% |
Cost of Revenue | 2.21 | 2.09 | 1.2 | 0.86 | 0.88 | 0.98 |
Gross Profit | 2.99 | 2.42 | 1.91 | 1.62 | 1.37 | 0.7 |
Selling, General & Admin | 4.15 | 3.37 | 2.09 | 3.87 | 2.28 | 2.54 |
Operating Expenses | 4.15 | 3.37 | 2.09 | 3.87 | 2.28 | 2.54 |
Operating Income | -1.16 | -0.94 | -0.18 | -2.24 | -0.91 | -1.84 |
Interest Expense | -0.26 | -0.21 | -0.19 | -0.18 | -0.06 | -0.05 |
Other Non Operating Income (Expenses) | 0.81 | 0.27 | -0.47 | -0.05 | -0.01 | -0.13 |
EBT Excluding Unusual Items | -0.61 | -0.88 | -0.84 | -2.47 | -0.99 | -2.03 |
Gain (Loss) on Sale of Assets | -0.07 | - | - | - | 0 | - |
Other Unusual Items | - | - | - | - | - | 0.04 |
Pretax Income | -0.68 | -0.88 | -0.84 | -2.47 | -0.98 | -1.99 |
Earnings From Continuing Operations | -0.68 | -0.88 | -0.84 | -2.47 | -0.98 | -1.99 |
Net Income | -0.68 | -0.88 | -0.84 | -2.47 | -0.98 | -1.99 |
Net Income to Common | -0.68 | -0.88 | -0.84 | -2.47 | -0.98 | -1.99 |
Shares Outstanding (Basic) | 13 | 9 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 13 | 9 | 3 | 3 | 3 | 3 |
Shares Change (YoY) | 326.39% | 212.41% | 2.17% | 2.14% | 7.30% | 34.52% |
EPS (Basic) | -0.05 | -0.09 | -0.28 | -0.85 | -0.34 | -0.75 |
EPS (Diluted) | -0.05 | -0.09 | -0.28 | -0.85 | -0.34 | -0.75 |
Free Cash Flow | 0.19 | 0.15 | 0.28 | -0.42 | -0.4 | -0.9 |
Free Cash Flow Per Share | 0.01 | 0.02 | 0.10 | -0.14 | -0.14 | -0.34 |
Gross Margin | 57.52% | 53.69% | 61.39% | 65.24% | 60.92% | 41.46% |
Operating Margin | -22.42% | -20.92% | -5.88% | -90.26% | -40.49% | -109.89% |
Profit Margin | -13.15% | -19.53% | -27.00% | -99.48% | -43.67% | -118.52% |
Free Cash Flow Margin | 3.70% | 3.24% | 9.06% | -16.73% | -17.70% | -53.76% |
EBITDA | -0.86 | -0.79 | -0.18 | -2.24 | -0.91 | -1.84 |
EBITDA Margin | -16.48% | -17.55% | -5.86% | -90.18% | -40.45% | -109.58% |
D&A For EBITDA | 0.31 | 0.15 | 0 | 0 | 0 | 0.01 |
EBIT | -1.16 | -0.94 | -0.18 | -2.24 | -0.91 | -1.84 |
EBIT Margin | -22.42% | -20.92% | -5.88% | -90.26% | -40.49% | -109.89% |
Revenue as Reported | 5.19 | 4.51 | 3.11 | 2.49 | 2.25 | 1.68 |
Advertising Expenses | - | 0.9 | 0.7 | - | - | - |